Huahai Pharmaceuticals (600521.SH): Two products have obtained drug registration certificates.

Smart Finance News App, Huahai Pharmaceutical (600521.SH) announced that the company recently received the "Drug Registration Certificate" for candesartan hydrochlorothiazide tablets (II) and rosoflurine acetic acid ester hydrochloride injections approved and issued by the National Medical Products Administration (referred to as "NMPA").